Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The USFDA has issued alert to health care providers, hospital supply managers, and pharmacists regarding lack of sterility assurance of drugs produced by ApotheCure and NuVision Pharmacy.
Subscribe to our email newsletter
The warning was based on ongoing inspection that raised lack of sterility assurance concerns in the facilities related to both the companies.
A voluntarily recall of all sterile products made and distributed by ApotheCure and all sterile lyophilized products made and distributed by NuVision is commenced by the respective companies.